King Lit Wong, Ph.D., has 20 years of experience managing worldwide patent portfolios as well as preparing and prosecuting patent applications related to pharmaceuticals, chemicals, polymers, biotechnology, biologics such as vaccines, antibodies, enzymes, and peptides, skin care products, cosmetics, nutraceuticals, diagnostics, medical devices, nanotechnology, fuel cells, and business methods in the United States and abroad. He also has extensive experience preparing and prosecuting design and plant patents. Dr. Wong has counseled clients on the strategy of worldwide patent procurement to meet their budgets and business objectives. He has advised clients on dealing with patent infringement issues. In addition, he has provided freedom-to-operate, invalidity, and patentability opinions for clients in the pharmaceutical, chemical, and biotechnology industries.
Dr. Wong was a partner in Kenyon & Kenyon, LLP for a number of years. He has authored 10 publications on the decisions of, or procedures in, the U.S. Court of Appeals for the Federal Circuit and the U.S. Patent and Trademark Office including the Patent Trial and Appeal Board (PTAB). He taught courses on advanced patent prosecution issues and the practices and strategy in PTAB patent proceedings.
Prior to practicing law, he was an Examiner in the U.S. Patent and Trademark Office in an organic chemical art unit examining patent applications on novel heterocyclic chemical compounds, and processes of making and using the chemical compounds. His scientific experience includes performing laboratory research in pharmacology and toxicology. He was a faculty member of the University of Pittsburgh lecturing on, among other subjects, pharmacokinetics. Dr. Wong has co-authored over 20 scientific articles published in peer-reviewed biomedical journals and the Encyclopedia Britannica.